Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3016% below fair value
$8.78−0.29 (-3.20%)
Close on Nov 18, 2026Market cap $334.41MP/E 24.4Yield –
Viemed Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Viemed Healthcare's revenue for the twelve months ending Jun 30, 2026 was $301.61M, up 25.2% year over year. For fiscal 2025 it was $270.28M, up 20.5% from the year before. The highest annual figure on record is $270.28M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.28M | +20.5% |
| FY2024 | Dec 31, 2024 | $224.26M | +22.5% |
| FY2023 | Dec 31, 2023 | $183.01M | +31.8% |
| FY2022 | Dec 31, 2022 | $138.83M | +18.6% |
| FY2021 | Dec 31, 2021 | $117.06M | -10.8% |
| FY2020 | Dec 31, 2020 | $131.31M | +63.6% |
| FY2019 | Dec 31, 2019 | $80.26M | +24.5% |
| FY2018 | Dec 31, 2018 | $64.46M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $78.10M | +23.9% |
| Q1 FY2026 | Mar 31, 2026 | $75.41M | +27.5% |
| Q4 FY2025 | Dec 31, 2025 | $76.18M | +25.5% |
| Q3 FY2025 | Sep 30, 2025 | $71.91M | +24.0% |
| Q2 FY2025 | Jun 30, 2025 | $63.06M | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $59.13M | +16.9% |
| Q4 FY2024 | Dec 31, 2024 | $60.70M | +19.6% |
| Q3 FY2024 | Sep 30, 2024 | $58.00M | +17.4% |
| Q2 FY2024 | Jun 30, 2024 | $54.97M | +26.9% |
| Q1 FY2024 | Mar 31, 2024 | $50.59M | +27.9% |
| Q4 FY2023 | Dec 31, 2023 | $50.74M | +35.3% |
| Q3 FY2023 | Sep 30, 2023 | $49.40M | +38.2% |
| Q2 FY2023 | Jun 30, 2023 | $43.31M | +30.0% |
| Q1 FY2023 | Mar 31, 2023 | $39.56M | +22.6% |
| Q4 FY2022 | Dec 31, 2022 | $37.51M | +17.4% |
| Q3 FY2022 | Sep 30, 2022 | $35.76M | +22.1% |
| Q2 FY2022 | Jun 30, 2022 | $33.31M | +21.6% |
| Q1 FY2022 | Mar 31, 2022 | $32.26M | +13.5% |
| Q4 FY2021 | Dec 31, 2021 | $31.96M | +2.4% |
| Q3 FY2021 | Sep 30, 2021 | $29.29M | -12.4% |
| Q2 FY2021 | Jun 30, 2021 | $27.40M | -36.1% |
| Q1 FY2021 | Mar 31, 2021 | $28.42M | +19.4% |
| Q4 FY2020 | Dec 31, 2020 | $31.20M | +45.5% |
| Q3 FY2020 | Sep 30, 2020 | $33.45M | +64.2% |
| Q2 FY2020 | Jun 30, 2020 | $42.85M | +110.8% |
| Q1 FY2020 | Mar 31, 2020 | $23.81M | +31.4% |
| Q4 FY2019 | Dec 31, 2019 | $21.45M | +16.8% |
| Q3 FY2019 | Sep 30, 2019 | $20.37M | +20.3% |
| Q2 FY2019 | Jun 30, 2019 | $20.33M | +33.6% |
| Q1 FY2019 | Mar 31, 2019 | $18.12M | +29.7% |
| Q4 FY2018 | Dec 31, 2018 | $18.36M | – |
| Q3 FY2018 | Sep 30, 2018 | $16.93M | – |
| Q2 FY2018 | Jun 30, 2018 | $15.21M | – |
| Q1 FY2018 | Mar 31, 2018 | $13.96M | – |
See a number that looks wrong?